---
title: News Releases | Beyond Cancer | beyondcancer
description: News Releases News
---

# News Releases

[All News](https://beyondcancer.com/news) [2023](https://beyondcancer.com/news/archive/2023) [2022](https://beyondcancer.com/news/archive/2022) [2021](https://beyondcancer.com/news/archive/2021)

## beyondcancer

[### Beyond Cancer Announces Approval by the Israeli Ministry of Health to Conduct a Phase 1b Clinical Trial Utilizing Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) in Combination with Anti-PD-

](https://beyondcancer.com/news/beyond-cancer-announces-approval-by-the-israeli-ministry-of-health-to-conduct-a-phase-1b-clinical-trial-utilizing-low-volume-ultra-high-concentration-nitric-oxide-lv-uno-)

December 3, 2024

[### Beyond Cancer Presents Promising Preclinical Data on Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting

](https://beyondcancer.com/news/beyond-cancer-presents-promising-preclinical-data-on-low-volume-ultra-high-concentration-nitric-oxide-lv-uno-therapy-at-the-2024-society-for-immunotherapy-of-cancer-sitc-)

November 11, 2024

[### Beyond Cancer to Present Preclinical Data of Ultra-High Concentration Nitric Oxide (UNO) Low Volume Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting

](https://beyondcancer.com/news/beyond-cancer-to-present-preclinical-data-of-ultra-high-concentration-nitric-oxide-uno-low-volume-therapy-at-the-2024-society-for-immunotherapy-of-cancer-sitc-annual-meet)

October 7, 2024

[### Beyond Cancer Presents First-in-Class Clinical Data Showing an Immunogenic Response in Subjects with r/r Unresectable Solid Tumors Treated with Ultra-High Concentration Nitric Oxide (UNO)

](https://beyondcancer.com/news/beyond-cancer-presents-first-in-class-clinical-data-showing-an-immunogenic-response-in-subjects-with-r-r-unresectable-solid-tumors-treated-with-ultra-high-concentration-n)

June 3, 2024

[### Beyond Cancer Selected to Present on the Clinical Development of Ultra-High Concentration Nitric Oxide (UNO) Therapy at the 2024 American Society of Clinical Oncology Annual Meeting

](https://beyondcancer.com/news/beyond-cancer-selected-to-present-on-the-clinical-development-of-ultra-high-concentration-nitric-oxide-uno-therapy-at-the-2024-american-society-of-clinical-oncology-annua)

May 1, 2024

[### Beyond Cancer™ Phase 1 Study Clears Cohort 1 in Patients with Advanced Relapsed or Refractory Unresectable Primary or Metastatic Cutaneous or Subcutaneous Solid Tumors    

](https://beyondcancer.com/news/beyond-cancer-phase-1-study-clears-cohort-1-in-patients-with-advanced-relapsed-or-refractory-unresectable-primary-or-metastatic-cutaneous-or-subcutaneous-solid-tumors)

December 26, 2023

[### Beyond Cancer™ Presents Positive First-in-Human Clinical Data for Ultra-High Concentration Nitric Oxide (UNO) Therapy in Solid Tumors During the Society for Immunotherapy of Cancer (SITC) 2023 Annual

](https://beyondcancer.com/news/beyond-cancer-presents-positive-first-in-human-clinical-data-for-ultra-high-concentration-nitric-oxide-uno-therapy-in-solid-tumors-during-the-society-for-immunotherapy-of)

November 3, 2023

[### Beyond Cancer™ Publishes Pre-Clinical Data in Cells Demonstrating that the Combination of Ultra-High Concentration Nitric Oxide (UNO) and Anti-mPD-1 Therapy Improves Tumor Regression Rates and Surviva

](https://beyondcancer.com/news/beyond-cancer-publishes-pre-clinical-data-in-cells-demonstrating-that-the-combination-of-ultra-high-concentration-nitric-oxide-uno-and-anti-mpd-1-therapy-improves-tumor-r)

October 17, 2023

[### Beyond Cancer™ Presents Positive Preclinical Data for Ultra-High Concentration Nitric Oxide (UNO) in Combination with Checkpoint Inhibitor Therapy During the 2023 AACR-NCI-EORTC International Conferen

](https://beyondcancer.com/news/beyond-cancer-presents-positive-preclinical-data-for-ultra-high-concentration-nitric-oxide-uno-in-combination-with-checkpoint-inhibitor-therapy-during-the-2023-aacr-nci-e)

October 16, 2023

[### Beyond Cancer™ Selected to Present Proffered Posters Discussing Data from the UNO Therapy Program at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

](https://beyondcancer.com/news/beyond-cancer-selected-to-present-proffered-posters-discussing-data-from-the-uno-therapy-program-at-the-2023-aacr-nci-eortc-international-conference-on-molecular-targets-)

October 4, 2023